GE HealthCare Technologies Common Stock Net 2020-2024 | GEHC
GE HealthCare Technologies common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.
- GE HealthCare Technologies common stock net for the quarter ending September 30, 2024 was $0.005B, a 0% increase year-over-year.
- GE HealthCare Technologies common stock net for 2023 was $0.005B, a INF% increase from 2022.
- GE HealthCare Technologies common stock net for 2022 was $0B, a NAN% decline from 2021.
- GE HealthCare Technologies common stock net for 2021 was $0B, a NAN% decline from 2020.
| GE HealthCare Technologies Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2023 | $5 |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $0 |
| GE HealthCare Technologies Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2024-09-30 | $5 |
| 2024-06-30 | $5 |
| 2024-03-31 | $5 |
| 2023-12-31 | $5 |
| 2023-09-30 | $5 |
| 2023-06-30 | $5 |
| 2023-03-31 | $5 |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | |
| 2021-09-30 | $0 |
| 2020-12-31 | $0 |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.464B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.382B | 25.94 |
| Stryker (SYK) | United States | $148.728B | 33.52 |
| Boston Scientific (BSX) | United States | $134.855B | 38.77 |
| EssilorLuxottica (ESLOY) | France | $111.549B | 0.00 |
| Medtronic (MDT) | Ireland | $108.676B | 16.14 |
| Haleon (HLN) | United Kingdom | $43.230B | 28.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.368B | 0.00 |
| ResMed (RMD) | United States | $35.759B | 29.39 |
| Terumo (TRUMY) | Japan | $29.367B | 41.47 |
| Koninklijke Philips (PHG) | Netherlands | $24.796B | 18.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.580B | 13.74 |
| Insulet (PODD) | United States | $18.378B | 73.18 |
| Baxter (BAX) | United States | $16.844B | 10.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.947B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.886B | 39.63 |
| Bio-Rad Laboratories (BIO) | United States | $9.115B | 30.98 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.071B | 14.11 |
| TG Therapeutics (TGTX) | United States | $5.378B | 0.00 |
| Haemonetics (HAE) | United States | $4.291B | 20.94 |
| Prestige Consumer Healthcare (PBH) | United States | $4.157B | 20.67 |
| ICU Medical (ICUI) | United States | $4.134B | 39.36 |
| Perrigo (PRGO) | Ireland | $3.694B | 10.88 |
| Envista Holdings (NVST) | United States | $3.681B | 27.42 |
| Agios Pharmaceuticals (AGIO) | United States | $3.167B | 0.00 |
| Neogen (NEOG) | United States | $3.159B | 36.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.782B | 17.84 |
| QuidelOrtho (QDEL) | United States | $2.548B | 16.40 |
| LeMaitre Vascular (LMAT) | United States | $2.380B | 57.85 |
| Warby Parker (WRBY) | United States | $2.366B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.977B | 34.59 |
| AtriCure (ATRC) | United States | $1.740B | 0.00 |
| InMode (INMD) | Israel | $1.552B | 9.34 |
| AdaptHealth (AHCO) | United States | $1.331B | 9.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.293B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.253B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.97 |
| Owens & Minor (OMI) | United States | $0.943B | 7.37 |
| National Vision Holdings (EYE) | United States | $0.910B | 30.40 |
| CeriBell (CBLL) | United States | $0.904B | 0.00 |
| Evolus (EOLS) | United States | $0.826B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.809B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.679B | 30.02 |
| Surmodics (SRDX) | United States | $0.561B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.561B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.554B | 0.00 |
| Quanterix (QTRX) | United States | $0.450B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.407B | 0.00 |
| ZimVie (ZIMV) | United States | $0.379B | 31.95 |
| Valneva SE (VALN) | France | $0.359B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.339B | 32.26 |
| Biote (BTMD) | United States | $0.334B | 7.31 |
| Sanara MedTech (SMTI) | United States | $0.326B | 0.00 |
| Cerus (CERS) | United States | $0.310B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.287B | 19.25 |
| Zynex (ZYXI) | United States | $0.258B | 54.07 |
| Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.12 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| MacroGenics (MGNX) | United States | $0.201B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.189B | 2.67 |
| Jin Medical (ZJYL) | China | $0.166B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.164B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 98.40 |
| Zevia PBC (ZVIA) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.50 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.75 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.10 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.079B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.071B | 36.67 |
| Exagen (XGN) | United States | $0.069B | 0.00 |
| Modular Medical (MODD) | United States | $0.067B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.053B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.033B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |